OraSure Gears For OTC HIV Test Trials, Faces Cryosurgery Distributor Shortfall
This article was originally published in The Gray Sheet
Executive Summary
OraSure Technologies is preparing to launch a series of studies in September to support potential over-the-counter use of its OraQuick Advance rapid HIV test
You may also be interested in...
Rapid HIV Test Firms Look To Local Government Contracts
The potential for large contracts with local governments is driving the sales strategies of rapid HIV test manufacturers
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.